Jacobs Levy Equity Management, Inc Global Blood Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $9.87 Million - $13.7 Million	-384,168 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $2.14 Million - $3.47 Million	86,117 Added 28.89%	384,168 $11.2 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $4.41 Million - $6.46 Million	172,956 Added 138.26%	298,051 $7.59 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $241,664 - $323,261	-7,445 Reduced 5.62%	125,095 $4.38 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $1.25 Million - $1.63 Million	-31,980 Reduced 19.44%	132,540 $5.4 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $5.84 Million - $9.89 Million	155,013 Added 1630.51%	164,520 $7.13 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $501,589 - $708,176	9,507 New	9,507 $524,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.